Ryvu Therapeutics SA

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -5.56% vs 20.81% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 28.41% vs 28.74% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.00",
          "val2": "18.00",
          "chgp": "-5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-15.00",
          "val2": "-22.70",
          "chgp": "33.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "2.10",
          "chgp": "4.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.40",
          "val2": "0.30",
          "chgp": "700.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-12.60",
          "val2": "-17.60",
          "chgp": "28.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,012.00%",
          "val2": "-1,362.70%",
          "chgp": "35.07%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -20.13% vs 66.31% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.16% vs -20.96% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62.30",
          "val2": "78.00",
          "chgp": "-20.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-112.70",
          "val2": "-135.30",
          "chgp": "16.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.80",
          "val2": "3.80",
          "chgp": "131.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "6.70",
          "chgp": "-110.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-101.20",
          "val2": "-111.40",
          "chgp": "9.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,962.20%",
          "val2": "-1,869.60%",
          "chgp": "-9.26%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

17.00

18.00

-5.56%

Operating Profit (PBDIT) excl Other Income

-15.00

-22.70

33.92%

Interest

2.20

2.10

4.76%

Exceptional Items

2.40

0.30

700.00%

Consolidate Net Profit

-12.60

-17.60

28.41%

Operating Profit Margin (Excl OI)

-1,012.00%

-1,362.70%

35.07%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -5.56% vs 20.81% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 28.41% vs 28.74% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

62.30

78.00

-20.13%

Operating Profit (PBDIT) excl Other Income

-112.70

-135.30

16.70%

Interest

8.80

3.80

131.58%

Exceptional Items

-0.70

6.70

-110.45%

Consolidate Net Profit

-101.20

-111.40

9.16%

Operating Profit Margin (Excl OI)

-1,962.20%

-1,869.60%

-9.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -20.13% vs 66.31% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 9.16% vs -20.96% in Dec 2024

All Annual Results